The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...

If future trials go well - now it has passed the first, Phase I, testing hurdle - it could become the longest-acting form of HIV prevention available. Currently, people can take daily pills or ...

Observed annually on March 10, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) 2025 serves as a crucial reminder of the ongoing fight against HIV/AIDS, particularly among women and girls.

It is uncommon to be able to interrupt ART for 12 weeks or longer, with the vast majority of people showing viral rebound by 4 weeks,” said Dr. Beatriz Mothe, Associate Investigator ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who ... timed to coincide with the presentation of the findings ...

Pepfar-supported health services integrate HIV services with tuberculosis care, treatment and prevention. And since 2019, Pepfar has been part of a partnership for screening and treating women ...

The CSC is raising awareness and conducting tests to control HIV/AIDS. District tuberculosis officer, Dr. Piyush Rai, said all patient details at the CSC and ART Center are kept confidential ...

The US government has not yet made clear whether it would honour the December announcement, but many key players fear that the Trump administration's recent termination of USAID-funded Pepfar projects ...

In today’s newsletter, Mia Malan explains how the twice-yearly HIV prevention jab, lenacapavir, will be rolled out with or without the US. Sign up for our newsletter today. The Global Fund for HIV, TB ...

Critical USAID-funded health projects in South Africa were forced to shut down, including some HIV testing and prevention services. This follows the mass termination of contracts globally from 26 ...